ArticleActa pharmacologica Sinica2025

The novel BCL-2/BCL-XL inhibitor APG-1252-mediated cleavage of GSDME enhances the antitumor efficacy of HER2-targeted therapy in HER2-positive gastric cancer.

Qiu-Yun Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.